SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-039969
Filing Date
2024-02-20
Accepted
2024-02-20 16:06:55
Documents
18
Period of Report
2024-02-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d768289d8k.htm   iXBRL 8-K 48756
2 EX-3.1 d768289dex31.htm EX-3.1 23700
3 EX-4.1 d768289dex41.htm EX-4.1 189057
4 EX-99.1 d768289dex991.htm EX-99.1 10503
8 GRAPHIC g768289g0220214211283.jpg GRAPHIC 4000
  Complete submission text file 0001193125-24-039969.txt   470046

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sybx-20240220.xsd EX-101.SCH 2860
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20240220_lab.xml EX-101.LAB 18740
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20240220_pre.xml EX-101.PRE 11714
20 EXTRACTED XBRL INSTANCE DOCUMENT d768289d8k_htm.xml XML 3868
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 24653272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)